Primary HematologyAyalew Tefferi Springer Science & Business Media, 1 dec. 2000 - 472 sidor Ayalew Tefferi, MD, and a team of authoritative practicing physicians concisely detail their most effective approaches to the diagnosis and treatment of a wide variety of hematological disorders, including anemia and other cytopenias, primary and secondary myeloproliferative disorders, lymphoid and plasma cell disorders, and thrombotic and bleeding disorders. For each illness these expert clinicians provide a brief review of basic concepts and a discussion of its symptomology and classification, its diagnostic tests, and strategies for its management, along with suggested readings for more detailed information. Numerous decision trees clarify diagnosis, and summary boxes highlight key points and dosage parameters. Concise, practical, and up-to-date, Primary Hematology offers busy primary care physicians, internists, hematologists, and oncologists a much-needed action-oriented summary of proven approaches to the optimal diagnosis and treatment of hematologic disorders today. |
Innehåll
Causes and Management of Isolated Thrombocytopenia | 105 |
An Approach to the Patient With Erythrocytosis | 119 |
Differential Diagnosis and Management of Thrombocytosis | 129 |
An Approach to the Patient With Myelodysplasia | 149 |
The Eosinophil and Eosinophilia | 161 |
Lymphadenopathy | 231 |
Hodgkins Disease and NonHodgkins Lymphoma | 241 |
An Evaluation of Patients With Monoclonal Gammopathies | 255 |
Thrombogenesis and Thrombotic Disorders | 317 |
Practical Issues | 339 |
A Disease for All Physicians | 351 |
Hematologic Manifestations of HIV Disease | 365 |
Hematopoietic Growth Factors in Clinical Practice | 371 |
A Primer of Chemotherapy | 379 |
Ethical Issues in the Care of Patients With Hematologic | 415 |
Statistical Methods Frequently Used in Hematology | 431 |
Multiple Myeloma and Related Disorders | 269 |
An Overview of the Hemostatic System and Interpretation | 291 |
An Overview and Clinical Practice | 303 |
451 | |
Andra upplagor - Visa alla
Vanliga ord och fraser
abnormalities acid activity agents AIHA allogeneic antibodies anticoagulant antigen aplastic associated autologous biopsy bleeding blood cell bone marrow transplantation cancer cause chemotherapy chromosome chronic clinical cytogenetic decreased diagnosis disorders donor dose drug electrophoresis enzyme eosinophil EPO level erythrocytosis erythropoietin evaluation factor ferritin folate G-CSF g/dL gene globin Hb F Hematology hematopoietic hemoglobin hemolysis hemolytic anemia hepatitis hydroxyurea increased infection initial intravascular intravenous iron deficiency laboratory leukocyte liver lymphocytic lymphoma M-protein malignant Mayo Foundation Medical monoclonal multiple myeloma mutation myelodysplastic syndrome myeloid myeloproliferative neutropenia neutrophil normal occurs oral patients peripheral blood peripheral smear plasma cells platelet platelet count polycythemia polycythemia vera porphyria presence production protein red cell risk serum EPO serum ferritin sickle cell anemia sickle cell disease splenectomy splenomegaly stem cell studies survival symptoms Table Tefferi thalassemia therapy thrombocytopenia thrombocytosis thrombosis tissue toxicity transfusion treatment tumor urine usually variants